Gujarat Themis Biosyn Limited (GUJTHEM) — Announcement | 13 July 2026

StockFin.ai

Try Free

📢 Key Event
Company settles arbitration dispute with Optimus Drugs without financial penalty.

💡 Investor Takeaway
The settlement removes legal risk without affecting the company's financial position.

Gujarat Themis Biosyn Limited disclosed that it has amicably settled a commercial arbitration dispute with Optimus Drugs Private Limited, resolving the matter without any financial penalty or material impact, as per SEBI LODR Regulation 30 disclosure.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GUJTHEM ✨ Ask AI About This

About Gujarat Themis Biosyn Limited (GUJTHEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,034.98 Cr P/E: 84.4

View full GUJTHEM stock details →

📡 Get AI alerts when GUJTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUJTHEM — Free

💡 Ask AI about this filing

"How does this settlement affect future litigation risk?" "What is the impact on GUJTHEM's credit rating?" "When will the arbitration case be formally closed?"

Ask AI Free →

📊 More GUJTHEM filings

See all GUJTHEM filings →

🔥 Also filed on 13 July 2026

RAMASTEEL Rama Steel Tubes Limited Announcement ANDHRAPAP ANDHRA PAPER LIMITED Corporate Action JUBLINGREA Jubilant Ingrevia Limited Financial Results POCL Pondy Oxides & Chemicals Limited Corporate Action MIRZAINT Mirza International Limited Insider Trading CAPITALSFB Capital Small Finance Bank Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GUJTHEM files new disclosures

Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GUJTHEM — Free

Free account · 2 AI queries/day